PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of narLink to Publisher's site
 
Nucleic Acids Res. 2010 October; 38(19): e183.
Published online 2010 August 11. doi:  10.1093/nar/gkq708
PMCID: PMC2965260

Selection systems based on dominant-negative transcription factors for precise genetic engineering

Abstract

Diverse tools are available for performing genetic modifications of microorganisms. However, new methods still need to be developed for performing precise genomic engineering without introducing any undesirable side-alteration. Indeed for functional analyses of genomic elements, as well as for some industrial applications, only the desired mutation should be introduced at the locus considered. This article describes a new approach fulfilling these requirements, based on the use of selection systems consisting in truncated genes encoding dominant-negative transcription factors. We have demonstrated dominant-negative effects mediated by truncated Gal4p and Arg81p proteins in Saccharomyces cerevisiae, interfering with galactose and arginine metabolic pathways, respectively. These genes can be used as positive and negative markers, since they provoke both growth inhibition on substrates and resistance to specific drugs. These selection markers have been successfully used for precisely deleting HO and URA3 in wild yeasts. This genetic engineering approach could be extended to other microorganisms.

INTRODUCTION

In the past decades, various systems have been established for genetic engineering of prototroph microorganisms, including wild yeasts. Powerful tools have been developed, in first instance using Saccharomyces cerevisiae, in the context of the collaborative genome sequencing and functional analysis projects (1–3). Classically, the first step consists in selecting linear vector integration by homologous recombination at the target locus. Then, internal vector elements are removed by homologous recombination between appropriately designed, directly repeated, flanking sequences (4). To perform genomic modifications in prototroph yeasts dominant selective markers leading to drug resistance are available, such as neo, which confers resistance to G418 (5), but convenient negative selection systems for subsequent elimination of vector sequences remained to be developed. Indeed, excision of the selectable marker spontaneously occurs by recombination between short directly repeated flanking sequences, but its frequency is very low (6). Therefore, genes encoding specific recombinases have been additionally used, together with specific pairs of target sequences included in the integrative vectors, which allowed increasing the homologous recombination frequency (7,8). Then, only a short piece of foreign DNA including the recombinase recognition sequence remains at the modified locus. However, for genetic engineering of various functional elements, but also for several applications involving industrial strains, vector excision leading to the elimination of all foreign DNA sequences is desired. Such requirements exclude the use of systems involving specific recombinases. Some years ago, Akada et al. (9) and Olesen et al. (10) developed a counter-selection method for vector recycling in S. cerevisiae based on conditioned over-expression of two particular genes (GIN11 and PKA3) encoding proteins which cause lethality when overproduced (9,10). These systems, combined with a positive marker, were successfully used in some industrial strains (9–11). However, they need to be adapted according to the behavior of a conditional promoter but also to the potency of the particular growth-inhibitory protein in the yeast host strain of interest (10). Considering these constraints and the diverse metabolic features of target hosts, it is obvious that new tools still need to be developed.

The approach described here is based on the use of expression cassettes encoding dominant-negative truncated transcription factors designed for interfering with specific regulatory pathways. Such defective transcription factors have been extensively used for fundamental research in higher eukaryotic cells, due to the difficulties of reverse genetics, or in view of therapeutic applications (12). However, in yeast as well as in many other microorganisms, this tool has only been marginally used, for studying metabolic functions (13–16). For genetic engineering of prototroph microorganisms, dominant-negative transcription factors would provide ideal tools. Indeed, this approach should allow the design of both positive and negative selection systems that are very efficient and should be appropriate for performing any precise genomic modification. Using such strategy, we performed several precise genetic modifications in two wild strains isolated from banana leaves in Thailand (17).

Two systems were established, respectively interfering with the catabolism of galactose and with the metabolism of arginine. In the absence of galactose, the transcriptional activator Gal4p is bound to specific sites (UAS) upstream the structural GAL genes, but is unable to activate their transcription, since the activation domain is masked by Gal80p (18). In the presence of galactose, the Gal4p activation domain is liberated. Consequently, expression of GAL1, GAL2, GAL7 and GAL10 is induced (19). To be efficient, the induction requires the relief of carbon catabolite repression.

A truncated transcription factor, Gal4pΔ (aa 1–147) is known to be localized in the nucleus and to bind to the UAS upstream the GAL genes, while being unable to activate their transcription in the presence of galactose (20–23). Overproduction of Gal4pΔ was expected to lead to competition with the endogenous Gal4p (which is produced at very low level) for binding to the DNA target sites, which should give rise to inhibition of induction in the presence of galactose, and to inhibition of growth on galactose as carbon source. We also expected that, when grown on a medium containing appropriate amounts of glucose and galactose, a yeast producing Gal4pΔ should be less sensitive to 2-deoxy-galactose (2DG), a pro-drug whose toxicity was previously demonstrated to be increased in strains constitutively producing the enzymes of the pathway (24). Therefore, a gene encoding Gal4pΔ was placed under the control of a strong constitutive promoter, in view of designing both positive and negative selection systems.

The arginine biosynthetic pathway consists of five enzymes allowing conversion of glutamate to ornithine, which is then converted in arginine in three steps [ornithine carbamoyltransferase (ARG3), argininosuccinate synthetase (ARG1) and lyase (ARG4)] (25). Arginine can be degraded by arginase (CAR1), giving rise to urea and ornithine which is modified by a transaminase (CAR2) into glutamate semialdehyde, giving rise to glutamate and ammonium after several steps. Regulation of arginine anabolic and catabolic pathways is dependent on the availability of arginine or ornithine as nitrogen source. Several regulatory systems are involved, including a specific transcriptional control which regulates the production of both anabolic and catabolic enzymes and involves the ‘ArgR–Mcm1p’ complex (26). When arginine or ornithine is used as nitrogen source, this complex binds specific sequences and activates the catabolic pathway, the anabolic pathway being simultaneously downregulated. In the absence of arginine or ornithine, the complex is formed but does not bind to DNA. Deletion of ARG81 leads to a growth defect on arginine or ornithine and to constitutive expression of genes encoding anabolic enzymes (27). In addition, such a mutant strain appeared to be resistant to canavanine (an arginine analog) toxicity (28), probably due to the accumulation of intracellular arginine. It has been shown that a truncated Arg81p (aa 1–180) can be included in a functionally defective complex (29). The dominant-negative factor evaluated in this study was then constitutively overproduced, and was expected to compete with the endogenous Arg81p for complex formation.

MATERIALS AND METHODS

Strains, culture media and chemicals

Escherichia coli strain XL1blue (Stratagen) was used for all cloning steps and was cultivated on LB medium. For selective medium, ampicillin was added at 100 µg/ml. Saccharomyces cerevisiae strains BY4709 (MATα ura3Δ0) (30), Σ1278b (MATα) (28), TR2 and TR3 (17) were used as model strains through the development of dominant negative marker. DNA of FY1679 (MATa ura3-52 his3Δ200/MATα his3Δ200 ura3-52) (31) has served as DNA template for cloning. These S. cerevisiae strains were cultivated on YPD and on minimum medium YNB with 80 mM ammonium and 20 mg/ml glucose (except for selection media and growth conditions for transcriptional analysis, see below). 2-Deoxy-d-galactose was purchased from MP Biomedicals and l-canavanine from Sigma-Aldrich.

Plasmid construction

All plasmids are described in Table 1. Cloning procedures are largely described in Supplementary Data.

Table 1.
List of plasmids used in this work

Transformation, positive and negative selection media

Saccharomyces cerevisiae strains were transformed using the lithium acetate procedure (32). For 108–109 harvested cells concentrated in 100 µl, at least 5 µg of integrative vector were added with 5 µg of carrier DNA (10 mg/ml fish sperm DNA solution, MB grade from Roche Diagnostics GmbH). For basic URA3 selection, transformants were selected on YNB, 20 mg/ml glucose. For GAL4Δ, the positive selection medium was YNB, 30 mg/ml glycerol, 20 mg/ml 2-deoxygalatose, 5 mg/ml casaminoacids, 1 mg/ml galactose, 200 µg/ml glucose, supplemented with 50 mg/l leucine or 25 mg/ml uracil if required. For ARG81Δ, the positive selection medium was YNB, 20 mg/ml glucose, 200 µg/ml ornithine and 25 µg/ml canavanine. Cells were not incubated in a non-selective growth medium before plating. Geneticin selection was performed as previously described (5).

The loss of integrative plasmid or deletion cassette was selected depending on the negative marker. First, transformants were cultivated overnight at 30°C during 24 h on YPD, diluted in fresh media to OD660 nm 0.05 and then grown for 24 h. Second, 104, 106 and 3 × 108 cfu were plated on selective media: YNB, 4 mg/ml galactose for GAL4Δ loss and YNB glucose, 1 mg/ml ornithine for ARG81Δ loss.

PCR characterization

All yeast transformants were characterized by PCR screening directly with colonies. First, cells were added to 10 µl of 0.25% SDS and heated at 95°C during 15 min. After this rapid DNA extraction, 90 µl of water were added and, after 1 min of centrifugation at 12 000g, 1 µl of supernatant was used as DNA template for PCR. The 25 µl-reaction mixture contained 0.4 µM of each primer, 0.8% Triton X100 and DreamTaq PCR MasterMix (Fermentas).

Sequencing of PCR fragments carrying genomic HO and URA3 deletions

Fragments carrying genomic HO and URA3 deletions were amplified by PCR with primer pairs ocej359/360 and ocej317/320, respectively (see Supplementary Table S1 for primer sequences). Fragments were purified by using High Pure PCR Product Purification Kit (Roche Diagnostics GmbH) and sequenced using the same primers (DNAvision S.A.).

Immunodetection by Western blot

After separation by SDS–PAGE, proteins were electroblotted onto a Hybond nitrocellulose membrane (GE Healthcare) with XcellII module (Invitrogen) and with NuPage Transfer Buffer (Invitrogen)/10% methanol. Tagged proteins were immunodetected with Anti-V5 antibodies (Invitrogen) and revealed by using Western-Breeze Chemiluminescent Kit Anti-Mouse (Invitrogen).

Quantitative qRT–PCR

Quantification of mRNA was performed as described previously (33). For inducing GAL genes expression, yeast strains were cultivated on YNB with 80 mM ammonium, 20 mg/ml raffinose until OD660 nm 0.5 in which 2 mg/ml galatose were added for a further 1-h growth. The anabolic and catabolic gene transcripts were quantified after growth on YNB with 80 mM ammonium, 20 mg/ml glucose in the presence or not of 1 mg/ml arginine. Total RNA was extracted as described previously (34). Primers amplified a 167-bp fragment of GAL1 (ocej235, 5′-CCGAAAAGTGCCCGAGCATA-3′; ocej236, 5′-GACGGCGCAAAGCATATCAA-3′), a 145-bp fragment of GAL2 (ocej237, 5′-TGAATTGAAAGCCGGTGAGT-3′; ocej238, 5′-GGTATCCCAGCCAAACATGA-3′), a 169-bp fragment of GAL10 (GAL10-O1, 5′-TGGGTTCCGGTAAAGGTTCT-3′; GAL10-O2, 5′-TGCAACTCGGTCTGCCATTT-3′), a 149-bp fragment of CAR1 (CAR1-O1, 5′-AATACCCCGATGCTGGTCTT-3′; CAR1-O2, 5′-TTTGAGCGACTCGGGACAAT-3′), a 100-bp fragment of ARG3 (ARG3-O1, 5′-GCCCGTGTGAACAAACATGA-3′; ARG3-O2, 5′-TTGCTTGCAAAGGGTGGAAT-3′) and a 125-bp fragment of TBP1 (TBP1-O1, 5′-TATAACCCCAAGCGTTTTGC-3′; TBP1-O2, 5′-GCCAGCTTTGAGTCATCCTC-3′).

Confocal imaging

Cells were imaged on LSM510-Axiovert 100 M confocal microscope (Zeiss) by exciting eGFP fusion at 488 nm.

RESULTS

Dominant-negative effects resulting from overexpression of GAL4Δ or ARG81Δ

To ensure a constitutive overproduction of truncated protein, the S. cerevisiae GAL4Δ sequence coding for Gal4pΔ (aa 1–147) was placed under the control of the strong TDH3 promoter. The ORF was fused or not to the V5 epitope coding sequence allowing immunodetection with V5-specific antibodies. The expression cassette was cloned in integrative vectors. The S. cerevisiae strain BY4709 was transformed with CYC1 integrative plasmids (described in Table 1) by conventional URA3 selection. Transformants harboring a single copy of the empty vector (p0int), plasmid with GAL4Δ (pGint) or plasmid carrying GAL4Δ:V5 (pGVint) were chosen after PCR characterization of genomic DNA (data not shown). The production of the truncated Gal4p was verified by immunodetection with V5-specific antibodies (Supplementary Figure S1). The phenotypes were determined by streaking the selected strains on minimal medium containing either glucose or galactose as sole carbon source. The growth of strains producing truncated Gal4p was significantly inhibited on galactose, indicating the occurrence of a dominant-negative effect (Figure 1). It should be noticed that this phenotype was slightly more pronounced with the GAL4Δ:V5 construct. This possibly results from a higher production level of Gal4pΔ-V5 (expression or half-live) or from a functional benefit due to this particular C-terminal modification of the protein (conformation, interaction with other transcription factors, etc.). Another plasmid, pGVGint, was constructed in order to overproduce Gal4pΔ as a fusion with GFP. The phenotype of a strain carrying such plasmid was similar to the one observed for pGVint. Observation by fluorescence microscopy revealed very efficient accumulation of the protein in the nucleus when GAL4Δ is expressed under the control of the strong TDH3 promoter (Figure 2). According to experiments described hereafter, the dominant-negative effect is due to interference of GAL4Δ with the induction of genes belonging to the galactose pathway. Indeed, the transcriptional analysis by qRT–PCR has shown a significant decrease of GAL1, GAL2 and GAL10 expression in raffinose grown strains carrying pGint or pGVint plasmids after 1-h pulse with galactose (Figure 3A). Expression of genes encoding defective transcription factors unrelated to the galactose pathway did not significantly affect expression of GAL genes (transcriptional analysis of GAL1, GAL2 and GAL10 in ARG81Δ:V5 expressing strain, data not shown) and growth on galactose (see below ARG81Δ).

Figure 1.
Phenotype determination of GAL4Δ and ARG81Δ expressing S. cerevisiae strains. BY4709-derived strains carrying the various integrated vectors were streaked on diverse media for identifying phenotypes. P0int: negative control vector; pGint: ...
Figure 2.
Subcellular localization of truncated Gal4p-V5 fused to GFP.
Figure 3.
(A) Transcriptional analysis of GAL1, GAL2 and GAL10 expression in wild-type (carrying empty CYC1 integrative plasmid p0int) and truncated Gal4p overproducing S. cerevisiae strains (harboring CYC1 integrative pGint and pGVint vectors, enabling the expression ...

By a similar approach, the S. cerevisiae ARG81 coding sequence spreading from ATG to codon 180 (ARG81Δ), fused or not to the V5 epitope coding sequence, was placed under the control of TDH3 promoter and cloned in an integrative plasmid. After transformation of BY4709 strain and selection of transformants harboring a single copy of these integrative plasmids, the production of Arg81pΔ was also verified by immunodetection with V5-specific antibodies (data not shown). The phenotype was verified by streaking cells on a minimal medium containing ornithine as sole nitrogen source. Growth of strains expressing ARG81Δ was inhibited in such medium (Figure 1), indicating that the production of truncated Arg81p is sufficient to establish a dominant-negative effect. The transcriptional analysis by qRT–PCR demonstrated a lower induction of catabolic CAR1 expression and a reduced repression of anabolic ARG3 expression in ARG81Δ-expressing strain when cells were grown in the presence of arginine, as compared to the wild-type strain (Figure 3B). This dominant-negative effect was also highlighted through enzymatic assays of the arginase and the ornithine transcarbamylase (data not shown). We also verified that production of truncated Arg81p does not significantly affect growth on galactose and that production of truncated Gal4p does not interfere with growth on ornithine, confirming the specificity of the dominant-negative effects (Figure 1).

Drug resistance due to dominant-negative effect of GAL4Δ and ARG81Δ

Various enzymes are able to convert specific prodrugs to toxic compounds and such property has been exploited for developing negative selection systems using particular mutant host strains (35,36). Such possibility was offered for the galactose pathway, and exploited in prototrophic host strains using GAL4Δ.

Resistance to 2DG, a glycolysis inhibiting prodrug whose toxic effect is supposed to require a permease (presumably Gal2p) and the Gal1p galactokinase (24,37), was evaluated. This required modification of the growth medium, as previous assays involved a wild-type strain and mutants constitutively expressing the GAL genes. Various assays were performed to define a medium allowing a GAL4 strain to be intoxicated by 2DG while GAL4Δ-expressing strains being able to grow. A defined medium was optimized in view of selection of transformants carrying GAL4Δ (data not shown). The optimal medium contains 1 mg/ml galactose to induce the GAL genes (whose expression is required for 2DG catabolism), a low concentration of glucose (0.2 mg/ml), 30 mg/ml glycerol (carbon sources for transformants carrying GAL4Δ) and 5 mg/ml casaminoacids (improving growth of transformants carrying GAL4Δ). The defined glucose concentration is apparently insufficient to impair the induction of GAL genes expression as well as galactose and deoxygalactose uptake. A reduced toxicity of this prodrug could be observed upon expression of GAL4Δ (Figure 1).

It was previously demonstrated that resistance to canavanine is encountered in can1 and argR mutants (38). ARG81Δ-expressing strains were streaked on a selection medium (YNB, 80 mM ammonium, 20 mg/ml glucose, 200 µg/ml ornithine, 8 µg/ml canavanine) rendering evident the canavanine resistance of argR mutants (38). As compared to the ARG81 control strain, ARG81Δ-expressing cells were resistant to the drug (Figure 1). ARG81Δ was then also potentially usable as positive selection marker.

Genetic engineering vectors for prototrophic S. cerevisiae strains

The selection through 2DG-resistance was assayed by transforming laboratory strains with a classical integrative plasmid carrying the GAL4Δ:V5 selective marker (Supplementary Figure S2). After transformation of Σ1278b (haploid strain) and BY4700/9 (diploid strain), tiny colonies were obtained after 5–7 days on 2DG medium, picked with the aid of a binocular and purified by streaking on a fresh 2DG selection plate. The small size of the transformants was probably due to the low glucose concentration in the 2DG medium (only 0.2 mg/ml) and the residual metabolic activity of non-transformed cells. More than 50% of diploid colonies harbored the expected disruption of the targeted allele, as shown by PCR analysis of genomic DNA (data not shown) and expected 2:2 leu2:LEU2 segregation was observed after sporulation. For Σ1278b, ~1% of 2DG-resistant clones appeared to carry the integrated vector. This lower efficiency probably results from a high frequency of spontaneous 2DG-resistant mutants (likely to be recessive, as not observed with the diploid). PCR-screening of the colonies should then be needed when transforming haploid strains. The efficiency of the negative selection system was demonstrated by selecting the vector excision event. Indeed, after growth on non-selective YPD medium and plating on minimal medium with galactose as sole carbon source, colonies showed a GAL4/LEU2 phenotype.

To further evaluate the efficiency of the GAL4Δ selection marker, gene deletions were performed in wild yeast strains (‘TR strains’) (17). As most of the S. cerevisiae wild strains, they are homothallic diploids, which implies that HO needs to be deleted for generating stable genetically modified recombinant strains (otherwise haploids of both mating types should appear after sporulation, giving rise spontaneously to a diploid cellular population by mating). For such purpose, a vector including a GAL4Δ selective marker surrounded by upstream and downstream HO sequences and an appropriate small 30 bp directly repeated HO sequence for subsequent vector excision was constructed (Table 1 and Figure 4). BamHI restriction sites were created for allowing the generation of appropriate DNA fragments for gene-replacement by homologous recombination.

Figure 4.
Scheme of integrative cassettes for the deletion of HO and URA3. All cassettes are excised from pUC19 plasmid by a BamHI double digest. Up sequences are identical to a sequence upstream of targeted ORF and down sequences are identical to a sequence downstream ...

TR3, a GAL and 2DG-sensitive diploid strain, was first chosen for performing genetic modifications with the GAL4Δ system. The pGVdelHO BamHI-digested vector was introduced into TR3 after transformation and selection on the 2DG medium. After 5 days, colonies were picked and purified by streaking on a fresh selection plate. PCR-characterization of genomic DNA has shown that >50% of the colonies exhibited the GAL4Δ:V5 cassette integrated in HO locus. After dissecting tetrads, stable ho haploids deriving from TR3 were obtained (2:2 HO:ho segregation). The integrated cassette in HO locus was then excised by spontaneous homologous recombination involving the small directly repeated HO sequences (Figure 5), by selecting haploid GAL clones after growth on YPD medium as described in ‘Materials and Methods’ section (PCR characterization, Supplementary Figure S3). The cassette pop-out frequency was estimated at 3 × 10−5 ± 6.5 × 10−6 from a set of three independent experiments. The expected accurate deletion of HO was confirmed by PCR-amplified genomic DNA sequencing. Among eight analyzed clones deriving from five independent transformants, seven carried the expected deletion (only one revertant showed an unexplained recombination event). Haploid strains of each mating type carrying the desired accurate HO deletion and devoid of any foreign DNA element were obtained and mated in order to generate a ho/ho diploid strain, TR3hoΔ.

Figure 5.
Scheme of gene deletion by homologous recombination between linearized integrative vectors and targeted genomic sequences, and subsequent excision by homologous recombination between the designed short (30 bp) directly repeated genomic sequences. ...

Afterwards, URA3 deletions were performed in TR3hoΔ strain to generate modified hosts that could be transformed with classical expression vectors. For this purpose, a vector carrying the GAL4Δ:V5 cassette surrounded by appropriate URA3 sequences was similarly constructed, pGVdelURA3 (Table 1 and Figure 4). Using the same approach, the deletion of URA3 was successfully carried out starting from the diploid strain with a transformation efficiency of >50%. Haploids of both mating types carrying expected accurate deletions of URA3, as confirmed by genomic DNA sequencing, were obtained. Successive genetic modifications of strains could systematically be performed in the same way, by transforming diploids and performing classical genetics. Indeed, such procedure allows verifying expected segregation of the genetic modifications and selecting modified haploids of both mating types. In comparison, transformation of TR3hoΔ-derived haploids was undertaken and, as mentioned above with Σ1278b, extensive PCR-screening was required (transformation efficiency of 7.8 ± 4.3%), confirming that the diploid-transformation procedure is more convenient.

Surprisingly, some TR strains appeared to be naturally 2DG-resistant despite their GAL phenotype. One of these, the TR2 diploid, was transformed using a construct in which a neo marker was associated to GAL4Δ (bidirectional TDH3-driven expression cassette), designed for the deletion of HO ORF (pGVKdelHO; Table 1 and Figure 4). After selection of G418-resistant transformants and PCR characterization, we observed a gal phenotype. Therefore, the dominant-negative effect of GAL4Δ does occur in such 2DG-resistant wild strain. Using haploids derived from these TR2 transformants, stable ho haploids devoid of foreign DNA sequences were obtained after spontaneous vector excision at a frequency of 1.4 × 10−4 ± 6 × 10−6 (based on three independent experiments). The neo/GAL4Δ expression cassette may then be convenient for modifying GAL strains that are not sensitive to 2DG (approach validated in BY4709 strain, data not shown). In addition, this vector provides an alternative for transformation of prototroph haploids (specifically in case only one mating type is available), as it avoids the PCR-screening of transformant candidates which was required with the 2DG selection due to the relatively high frequency of non-transformed 2DG-resistant haploid clones as mentioned above.

We also used the ARG81Δ marker for modifying the 2DG-resistant TR2 strain, with an optimized selective medium with canavanine (25 µg/ml). Using BamHI-digested pAVdelHO (Table 1 and Figure 4), deletion of HO was successfully carried out (data not shown). After sporulation, ho haploids of both mating types were obtained. The growth of these ho haploids on ornithine as nitrogen source was inhibited, as expected, allowing selection of vector excision after growth on non-selective YPD medium, at a frequency of 5.5 × 10−5 ± 1.6 × 10−5. The expected accurate deletion of HO gene was confirmed by PCR-amplified genomic DNA sequencing. The ARG81Δ marker may then provide a useful alternative for modifying 2DG-resistant strains.

In order to compare efficiencies of the 2DG and canavanine positive selection systems, a series of transformation experiments were performed with the HO and URA3 deletion vectors in TR2 and TR3 strains (Table 2). These results demonstrate that the two selection systems have similar efficiencies. A set of convenient vectors harboring GAL4Δ and ARG81Δ was developed (see Figure 6 and plasmid sequences in Supplementary Data). With such plasmids, the introduction of homologous sequences to loci to be targeted can be easily carried out via two polylinkers flanking the selection cassette.

Table 2.
Evaluation of transformation efficiencies for HO deletion in TR3 by pGVdelHO (2-deoxygalactose selection), URA3 deletion in H2n1 (ho/ho diploid derived from TR3) by pGVdelURA (2DG selection) and HO deletion in TR2 by pAVdelHO (canavanine selection)
Figure 6.
Plasmid maps of pCSC129, 130 and 131 containing GAL4Δ, ARG81Δ and GAL4Δ/KanMX4 selection markers respectively. These vectors are derived from pUC19 and contain two convenient polylinkers, BglII-AvrII-NotI and MluI-KpnI-BamHI, to ...

CONCLUSION

The use of dominant-negative truncated transcription factors designed for interfering with specific regulatory pathways has been shown to allow performing precise genetic modification of wild strains of S. cerevisiae. This method should be convenient for performing any site-directed modification [including point-mutations, as described in ref. (6)] in the genome, and avoids side-alterations in the locus, which is useful for a number of functional studies. The approach is based on the use of a single expression cassette leading to both resistance to a toxic compound and inhibition of growth on a specific substrate. It is particularly attractive for specific applications, such as building of genetically modified strains for the food industry, as only specific genes derived from the host strain should be used (avoiding the utilization of foreign genes). The described method is also more powerful than previously described systems such as 5-fluoroorotic acid resistance of ura3 strains. Indeed, it does not require previous generation of a specific mutation or deletion. Moreover, in the specific case of the Saccharomyces wild strains, a preliminary deletion of HO is required for generating stable haploids, and the growth defect resulting from transcriptional interference appeared to be very convenient for subsequent vector recycling.

Resistance to a drug resulting from interference with a specific regulatory pathway is apparently not as systematically observed than metabolic alteration leading to growth inhibition. Indeed, not all the GAL wild strains appeared to be sensitive to 2DG in the various growth conditions assayed (data not shown). However, transformation of the 2DG-resistant diploid TR2 using a neo marker associated to the GAL4Δ cassette gave rise to transformants that were deficient for growth on galactose. Therefore, the transcriptional interference occurred, and the counter-selection was adequate for selection of subsequent vector excision on the galactose medium. We could not explain such resistance behavior on 2DG, as the toxicity of this prodrug through inhibition of glycolysis is not fully understood (37). Possibly, 2DG is not transported by the galactopermease or the derivative compound (2-deoxygalactose-1-phosphate and/or UDP-2-deoxygalactose) is not efficiently produced or else its toxic effect is not exerted in all GAL strains. In case of TR2, canavanine appeared to be toxic, and ARG81Δ was successfully used as positive/negative selection marker, which offers an useful alternative to GAL4Δ.

Based on the existing knowledge on metabolic pathways and regulatory genes, it should be possible to design a number of alternative dominant-positive/negative selection systems (see phenotypes database of Saccharomyces Genome Database). Systematic studies could be designed which should allow generating both useful knowledge on known or predicted transcription factors as well as identifying new selective markers of interest, by searching for dominant-negative phenotypes upon transformation with appropriate constructs involving the neo positive marker, for example.

The approach could be extended to other yeasts, but also to other microorganisms. Data generated in the context of genomic sequencing projects allow identifying an increasing number of candidate genes for generating such modified transcription factors. For genetic modification of diploid wild strains of Saccharomyces, the use of modified transcription factors appeared to be particularly efficient. In this respect, it should be noticed that diploidy or polyploidy has been observed in the case of various wild microorganisms (various lower eukaryotes, but also bacteria and archaea) (39–41).

SUPPLEMENTARY DATA

Supplementary Data are available at NAR Online.

FUNDING

Commission Communautaire Française. Funding for open access charge: a.s.b.l. Meurice Recherches & Développement.

Conflict of interest statement. None declared.

Supplementary Material

Supplementary Data:

ACKNOWLEDGEMENTS

The authors thank Christianne Legrain for her proofread of this article, Fabienne Vierendeels for technical support, André Feller for technical advices and Magali Plas for her conscientious work during her student term.

REFERENCES

1. Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, Andre B, Bangham R, Benito R, Boeke JD, Bussey H, et al. Functional characterization of the S.cerevisiae genome by gene deletion and parallel analysis. Science. 1999;285:901–906. [PubMed]
2. Giaver G, Chu AM, Ni L, Connelly C, Riles L, Véronneau S, Dow S, Lucau-Danila A, Anderson K, André B, et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature. 2002;418:387–391. [PubMed]
3. Scherens B, Goffeau A. The uses of genome-wide yeast mutant collections. Genome Biol. 2004;5:229. [PMC free article] [PubMed]
4. Johnston M, Riles L, Hegemann JH. Gene disruption. Methods Enzymol. 2000;350:290–315. [PubMed]
5. Wach A, Brachat A, Pöhlmann R, Philippsen P. New heterologous modules for classical or PCR-based gene disruption in Saccharomyces cerevisiae. Yeast. 1994;10:1793–1808. [PubMed]
6. Längle-Rouault F, Jacobs E. A method for performing precise alterations in the yeast genome using a recyclable selectable marker. Nucleic Acids Res. 1995;23:3079–3081. [PMC free article] [PubMed]
7. Sauer B. Functional Expression of the cre-lox Site-Specific Recombination System in the Yeast Saccharomyces cerevisiae. Mol. Cell. Biol. 1987;7:2087–2096. [PMC free article] [PubMed]
8. Güldener U, Heck S, Fielder T, Beinhauer J, Hegemann JH. A new efficient gene disruption cassette for repeated use in budding yeast. Nucleic Acids Res. 1996;24:2519–2524. [PMC free article] [PubMed]
9. Akada R, Matsuo K, Aritomi K, Nishizawa Y. construction of recombinant sake yeast containing a dominant FAS2 mutation without extraneous sequences by a two-step gene replacement protocol. J. Biosci. Bioeng. 1999;87:43–48. [PubMed]
10. Olesen K, Johannesen P, Hoffmann L, Sorensen S, Gjerlansen C, Hansen J. The pYC plasmids, a series of cassette-based yeast plasmid vectors providing means of counter-selection. Yeast. 2000;16:1035–1043. [PubMed]
11. Hirosawa I, Aritomi K, Hoshida H, Kashiwagi S, Nishizawa Y, Akada R. Construction of a self-cloning sake yeast that overexpresses alcohol acetyltransferase gene by a two-step gene replacement protocol. Appl. Microbiol. Biotechnol. 2004;65:68–73. [PubMed]
12. Urnov F, Rebar E, Reik A, Pandolfi P. Designed transcription factors as structural, functional and therapeutic probes of chromatin in vivo. EMBO Rep. 2002;3:610–615. [PubMed]
13. Caponigro G, Abedi MR, Hurlburt AP, Maxfield A, Judd W, Kamb A. Transdominant genetic analysis of a growth control pathway. Proc. Natl Acad. Sci. USA. 1998;95:750–7513. [PubMed]
14. Vélot C, Srere P. Reversible transdominant inhibition of a metabolic pathway. J. Biol. Chem. 2000;275:12926–12933. [PubMed]
15. Boyer J, Badis G, Fairhead C, Talla E, Hantraye F, Fabre E, Fischer G, Hennequin C, Koszul R, Lafontaine I, et al. Large-scale exploration of growth inhibition caused by overexpression of genomic fragments in Saccharomyces cerevisiae. Genome Biol. 2004;5:R72. [PMC free article] [PubMed]
16. Ortiz P, Kinzy T. Dominant-negative mutant phenotypes and the regulation of translation elongation factor 2 levels in yeast. Nucleic Acids Res. 2005;33:5740–5748. [PMC free article] [PubMed]
17. Koedrith P, Dubois E, Scherens B, Jacobs E, Boonchird C, Messenguy F. Identification and characterization of a thermotolerant yeast strain isolated from banana leaves. Sci. Asia. 2008;34:147–152.
18. Nogi Y, Fukasawa T. Functional domains of a negative regulatory protein, GAL80, of Saccharomyces cerevisiae. Mol. Cell. Biol. 1989;9:3009–3017. [PMC free article] [PubMed]
19. Johnston M. A model fungal gene regulatory mechanism: the GAL genes of Saccharomyces cerevisiae. Microbiol. Rev. 1987;51:458–476. [PMC free article] [PubMed]
20. Silver P, Keegan L, Ptashne M. Amino terminus of the yeast GAL4 gene product is sufficient for nuclear localization. Proc. Natl Acad. Sci. USA. 1984;81:5951–5955. [PubMed]
21. Gill G, Ptashne M. Negative effect of transcriptional activator GAL4. Nature. 1988;334:721–724. [PubMed]
22. Carey M, Kakidani H, Leatherwood J, Mostashari F, Ptashne M. An amino-terminal fragment of GAL4 binds DNA as a dimer. J. Mol. Biol. 1989;209:423–432. [PubMed]
23. Chasman D, Kornberg R. GAL4 protein: purification, association with GAL80 protein, and conserved domain structure. Mol. Cell. Biol. 1990;10:2916–2923. [PMC free article] [PubMed]
24. Platt T. Toxicity of 2-deoxygalactose to Saccharomyces cerevisiae cells constitutively synthesizing galactose-metabolizing enzymes. Mol. Cell. Biol. 1984;4:994–996. [PMC free article] [PubMed]
25. Messenguy F, Dubois E. Regulation of arginine metabolism in Saccharomyces cerevisiae: a network of specific and pleiotropic proteins in response to multiple environmental signals. Food Technol. Biotechnol. 2000;38:277–285.
26. Messenguy F, Dubois E. Role of MADS box proteins and their cofactors in combinatorial control of gene expression and cell development. Gene. 2003;316:1–21. [PubMed]
27. Qiu H, Dubois E, Messenguy F. Dissection of the bifunctional ARGRII protein involved in the regulation of arginine anabolic and catabolic pathways. Mol. Cell. Biol. 1991;11:2169–2179. [PMC free article] [PubMed]
28. Grenson M, Mousset M, Wiame J, Béchet J. Multiplicity of the amino acid permeases in Saccharomyces cerevisiae. Biochim. Biophys. Acta. 1966;127:325–338. [PubMed]
29. Amar N, Messenguy F, El Bakkoury M, Dubois E. ArgRII, a component of the ArgR-Mcm1 complex involved in the control of arginine metabolism in Saccharomyces cerevisiae, is the sensor of arginine. Mol. Cell. Biol. 2000;20:2087–2097. [PMC free article] [PubMed]
30. Brachmann C, Davies A, Cost G, Caputo E, Li J, Hieter P, Boeke JD. Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast. 1998;14:115–132. [PubMed]
31. Winston F, Dollard C, Ricupero-Hovasse S. Construction of a set of convenient Saccharomyces strains that are Isogenic to S288C. Yeast. 1995;11:53–55. [PubMed]
32. Ito H, Fukuda Y, Murata K, Kimura A. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 1983;153:163–168. [PMC free article] [PubMed]
33. Georis I, Tate J, Cooper T, Dubois E. Tor pathway control of the nitrogen-responsive DAL5 gene bifurcates at the level of Gln3 and Gat1 regulation in Saccharomyces cerevisiae. J. Biol. Chem. 2008;283:8919–8929. [PubMed]
34. Schmitt ME, Brown TA, Trumpower BL. A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. Nucleic Acids Res. 1990;18:3091–3092. [PMC free article] [PubMed]
35. Boeke JD, Lacroute F, Fink GR. A positive selection for mutants lacking orotidine-5′-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Mol. Gen. Genet. 1984;197:345–346. [PubMed]
36. Hartzog P, Nicholson B, McCusker J. Cytosine deaminase MX cassettes as positive/negative selectable markers in Saccharomyces cerevisiae. Yeast. 2005;22:789–798. [PubMed]
37. Lagunas R, Moreno E. Inhibition of glycolysis by 2-deoxygalactose in Saccharomyces cerevisiae. Yeast. 1992;8:107–115. [PubMed]
38. Béchet J, Grenson M, Wiame JM. Mutations affecting repressibility of arginine biosynthetic enzymes in Saccharomyces cerevisiae. Eur. J. Biochem. 1970;12:31–39. [PubMed]
39. Tobiason D, Seifert H. The Obligate Human Pathogen, Neisseria gonorrhoeae, Is Polyploid. PLoS Biol. 2006;4:1069–1078. [PMC free article] [PubMed]
40. Michelsen O, Hansen F, Albrechtsen B, Jensen P. The MG1363 and IL1403 laboratory strains of Lactococcus lactis and several dairy strains are diploid. J. Bacteriol. 2010;192:1058–1065. [PMC free article] [PubMed]
41. Breuert S, Allers T, Spohn G, Soppa J. Regulated polyploidy in halophilic archaea. PLos One. 2006;1:e92. [PMC free article] [PubMed]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press